XTX Topco’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$191K Sell
11,772
-1,820
-13% -$32.2K ﹤0.01% 2859
2025
Q4
$254K Sell
13,592
-2,946
-18% -$48.9K 0.01% 2212
2025
Q3
$241K Buy
+16,538
New +$209K 0.01% 1682
2025
Q2
Sell
-19,759
Closed -$176K 3151
2025
Q1
$176K Buy
19,759
+3,403
+21% +$31.7K 0.01% 1733
2024
Q4
$154K Sell
16,356
-4,083
-20% -$37.2K 0.01% 1652
2024
Q3
$165K Buy
20,439
+5,243
+35% +$45.4K 0.01% 1499
2024
Q2
$129K Buy
+15,196
New +$137K 0.01% 1360
2022
Q4
Sell
-20,410
Closed -$207K 1498
2022
Q3
$207K Buy
+20,410
New +$191K 0.05% 757
2021
Q3
Sell
-14,269
Closed -$207K 1049
2021
Q2
$207K Buy
+14,269
New +$268K 0.07% 549

Other funds holding TBPH